Copyright
©The Author(s) 2017.
World J Transplant. Feb 24, 2017; 7(1): 34-42
Published online Feb 24, 2017. doi: 10.5500/wjt.v7.i1.34
Published online Feb 24, 2017. doi: 10.5500/wjt.v7.i1.34
Factor | DGF n = 135 (%) | PGF n = 292 (%) | P value | |
Recipient age | Years (mean) | 51.43 ± 12.19 | 47.45 ± 13.93 | 0.0046 |
Donor age | Years (mean) | 51.56 ± 13.05 | 47.00 ± 15.99 | 0.0041 |
Recipient gender | Male | 105 (77.8) | 178 (61.0) | 0.0009 |
Female | 30 (22.2) | 114 (39.0) | ||
Donor gender | Male | 69 (51.1) | 123 (42.1) | 0.12 |
Female | 66 (48.9) | 167 (57.2) | ||
Ethnicity | Black | 35 (25.9) | 41 (14.0) | 0.004 |
Non-black | 100 (74.1) | 251 (86.0) | ||
Time on RRT | Years (mean) | 6.37 ± 5.44 | 5.00 ± 5.07 | 0.012 |
Regrafts | 1st | 114 (84.4) | 261 (89.4) | 0.2 |
> 2nd | 21 (15.6) | 31 (10.6) | ||
Donation type | DCD | 45 (33.3) | 32 (11.0) | < 0.00001 |
DBD | 90 (66.6) | 259 (88.7) | ||
CIT | Hours (mean) | 24.70 ± 7.82 | 21.29 ± 7.58 | 0.000023 |
HLA mismatch | Mean | 3.47 ± 1.30 | 3.19 ± 1.58 | 0.079 |
Preformed DSA | DSA+ | 17 (12.6) | 18 (6.2) | 0.039 |
DSA- | 118 (87.4) | 274 (93.8) | ||
Induction | Alemtuzumab | 113 (83.7) | 292 (84.9) | 0.86 |
IL2RA | 22 (16.3) | 44 (15.1) | ||
Recipient Diabetes | Yes | 35 (25.9) | 46 (15.8) | 0.02 |
No | 100 (74.1) | 246 (84.2) |
- Citation: Willicombe M, Rizzello A, Goodall D, Papalois V, McLean AG, Taube D. Risk factors and outcomes of delayed graft function in renal transplant recipients receiving a steroid sparing immunosuppression protocol. World J Transplant 2017; 7(1): 34-42
- URL: https://www.wjgnet.com/2220-3230/full/v7/i1/34.htm
- DOI: https://dx.doi.org/10.5500/wjt.v7.i1.34